According to the Zhitong Finance App, Kehua Biotech (002022.SZ) released a report for the first quarter of 2023. The company's operating income during the reporting period was 833 million yuan, an increase of 98.13% over the previous year; net profit attributable to shareholders of listed companies was 54.7619 million yuan, an increase of 145.75% over the previous year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 48.1412 million yuan, an increase of 130.37% over the previous year; basic earnings per share were 0.1065 yuan.
科华生物(002022.SZ)发一季度业绩，净利润5476.19万元，同比增长145.75%
Kehua Biotech (002022.SZ) released first-quarter results, with net profit of 54.7619 million yuan, an increase of 145.75% over the previous year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.